Close

Revance Therapeutics (RVNC) Provides Update on RT001 Clinical Program

October 1, 2014 4:04 PM EDT Send to a Friend
Revance Therapeutics, Inc. (Nasdaq: RVNC) today announced that the company has initiated a study to confirm this quarter the successful ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login